Texas Oncology - Northeast Texas

Clinical research site in Allen, Texas

Part of US Oncology

As of July 2026, 5 paid clinical trials are recruiting at Texas Oncology - Northeast Texas in Allen, Texas. Active studies at this site cover conditions such as Breast Cancer, Breast Neoplasms and Non-Small Cell Lung Cancer Metastatic. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Texas Oncology - Northeast Texas (5)

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Advanced Non-Small Cell Lung Cancer

186 locations incl. Bullhead City

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for Non-small Cell Carcinoma

133 locations incl. Alabaster

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for Breast Cancer

102 locations incl. Chandler

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07062965·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for Breast Cancer

169 locations incl. Daphne

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

for Breast Cancer

134 locations incl. Daphne

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06966453·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

More research sites in Allen

Texas Oncology-Northeast Texas (4 trials)
Arthritis and Rheumatology Research Institute (4 trials)
Allen Arthritis (2 trials)
Arthritis & Rheumatology Institute - Allen (2 trials)
Arthritis & Rheumatology Research Institute, PLLC (2 trials)
Anthos Investigative (1 trial)
Arthritis & Rheumatology Institute (1 trial)
Arthritis & Rheumatology Research Institute (1 trial)
Arthritis and Rheumatology Ins (1 trial)
Arthritis and Rheumatology Research Institute PLLC (1 trial)

Explore more

Paid clinical trials in Allen, TX · Texas clinical trials